Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 2,581-2,592 of 10,612
Drug study icon
WithdrawnNCT02418702

A Study to Decrease Suicidal Thinking Using Ketamine

This summary needs review. Please check the official study record and contact the research team for details.

In United States
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
United States Naval Medical Center, San Diego
Condition
Depression
Drug study icon
CompletedNCT00880217

3 Different Doses of JNJ-31001074 for ADHD

This study is completed in the United States. It is testing 3 Different Doses of JNJ-31001074 for ADHD.

In United States
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
ADHD
Drug study icon
CompletedNCT01655680

ABT-126 for schizophrenia

This study is completed in the United States, in the United Kingdom, and in Russia. It is testing ABT-126 for schizophrenia.

In United States
SchizophreniaDrugFrom 20 Years to 65 Years
Countries
United States, United Kingdom, Russia
Sponsor
AbbVie (prior sponsor, Abbott)
Condition
Schizophrenia
Drug study icon
CompletedNCT01192880

Bitopertin for schizophrenia

This study is completed in the United States, in Bulgaria, in China, .... It is testing bitopertin for schizophrenia.

In United States
SchizophreniaDrugOver 18 Years
Countries
United States, Bulgaria, China, ...
Sponsor
Hoffmann-La Roche
Condition
Schizophrenia
Drug study icon
CompletedNCT02942004

SAGE-547 for depression

This study is completed in the United States. It is testing SAGE-547 for depression.

In United States
DepressionDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
WithdrawnNCT05344365

Iloperidone for Schizophrenia

This study was withdrawn in the United States. It is testing iloperidone for Schizophrenia.

In United States
SchizophreniaDrugOver 65 Years
Countries
United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.